Start with validated glucose-based tests
Routine screening and diagnosis generally use A1C, fasting plasma glucose, or an oral glucose tolerance test.
A1C estimates longer-term glucose exposure and does not require fasting. Fasting plasma glucose measures one point after an appropriate fast. An oral glucose tolerance test measures fasting and timed values after a standardized glucose drink. These tests can disagree because they capture different physiology and time windows. Bring the original report instead of a recollection. A clinician decides whether the value is normal, in a prediabetes range, or in a diabetes range and whether confirmation is needed.
Understand what fasting insulin can and cannot do
An insulin result may add context, but it lacks a universal routine diagnostic threshold.
Insulin assays differ across laboratories, and values change with fasting duration, recent food, illness, medicines, body size, puberty, pregnancy, and population. Calculations such as HOMA-IR were developed for research or population use and inherit measurement limitations. Do not paste a value into an online calculator and self-diagnose. Ask why the clinician ordered insulin, which method and reference interval were used, and how the answer would change treatment beyond what glucose and overall risk already show.
Check whether A1C is reliable in your situation
A1C depends on red blood cells as well as glucose.
Recent blood loss or transfusion, anemia, kidney or liver disease, pregnancy, and some hemoglobin variants can make A1C less representative. Laboratory methods also matter. If A1C and plasma glucose do not match, the correct response is not to choose the preferred number; it is to review the context and consider repeat or alternative testing. Consumer wearables and home meters can show patterns but do not substitute for appropriately collected diagnostic laboratory tests.
Assess the broader cardiometabolic pattern
Insulin-related risk is not captured by one glucose or insulin value.
A clinician may review triglycerides, HDL and LDL cholesterol, blood pressure, waist measurement, weight trajectory, family history, pregnancy history, polycystic ovary syndrome, fatty liver, sleep, activity, nutrition, and medicines. These features can influence screening and prevention but are not each a stand-alone insulin-resistance test. Selective liver, thyroid, or other evaluation should follow the history and examination instead of an indiscriminate panel.
Turn the result into a measured plan
Ask what the test establishes, what remains uncertain, and when the outcome will be checked again.
The plan may include nutrition, activity, sleep, weight management, medication review, or treatment of prediabetes or diabetes. If sleep apnea is suspected because of snoring, gasping, breathing pauses, or marked sleepiness, it needs its own evaluation and appropriate sleep test. Better sleep may support metabolic care but does not prove glucose normalization. Record the owner, repeat date, target outcome, and symptoms that require earlier contact.
Appointment checklist
Create a laboratory interpretation sheet
Put every result in context before drawing a conclusion or changing treatment.
- 1
Identify the test
Record A1C, fasting plasma glucose, two-hour glucose, fasting insulin, lipid, liver, or other test; specimen; units; lab range; collection date; and ordering reason.
- 2
Record preparation
Note fasting duration, illness, sleep loss, pregnancy when relevant, exercise, alcohol, time of day, and any deviation from instructions.
- 3
List accuracy modifiers
Include anemia, hemoglobin variant, kidney or liver disease, blood loss or transfusion, medicines, supplements, and recent medication changes.
- 4
Define the decision
Ask whether the result diagnoses anything, requires confirmation, changes treatment now, or simply changes the timing and type of follow-up.
Common questions
Questions patients ask first
What is a normal fasting insulin level?
Laboratory ranges and assays vary, and there is no single universal fasting-insulin cutoff that diagnoses insulin resistance in routine care. Interpret the result with the ordering clinician and the exact laboratory method.
Can A1C detect insulin resistance?
A1C can identify chronic glucose exposure in normal, prediabetes, or diabetes ranges, but it does not directly measure insulin sensitivity. Insulin resistance may be present before A1C rises.
Is HOMA-IR a diagnostic test?
HOMA-IR is used in research and selected clinical contexts, but cutoffs vary by assay and population. It should not be treated as a universal self-diagnostic score.
Do I need every metabolic lab at once?
Not necessarily. Testing should answer a clinical question. The clinician can choose glucose, lipids, liver, thyroid, or other studies based on age, symptoms, history, medicines, pregnancy, examination, and prior results.
Authoritative sources
Review the public guidance
- NIDDK: Insulin Resistance and Prediabetes
- NIDDK: Diabetes Tests and Diagnosis
- CDC: Insulin Resistance and Type 2 Diabetes
Medically reviewed by Domenico Savatta, MD, FACS on July 23, 2026. Source links support education, not a personal recommendation.
